Press releaseGlobe Newswire
Corbus Pharmaceuticals Holdings
CRBP · NASDAQ
$4.42−$0.04 (−0.90%)TodayMarket closed ·
Prev close $4.46
Latest news
- NewsVandana Singh
Corbus Pharmaceuticals Obesity Drug Avoids 'Depressive Effects'
- News
Market-Moving News for September 14th
- Press releaseGlobe Newswire
Corbus Pharmaceuticals Announces Positive Topline Data from CANYON-1 Study of Daily Oral CRB-913 for the Treatment of Obesity
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- Press releaseGlobe Newswire
Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity
- Press releaseGlobe Newswire
Corbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update
- Press releaseGlobe Newswire
Corbus Pharmaceuticals Announces Last Patient Last Visit in CANYON-1 Study of CRB-913 for the Treatment of Obesity
- Press releaseGlobe Newswire
Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer
- Press releaseGlobe Newswire
Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- Press releaseGlobe Newswire
Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers
- Press releaseGlobe Newswire
Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call
- Press releaseGlobe Newswire
Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors
- Press releaseGlobe Newswire
Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update
- News
Corbus Pharmaceuticals Q4 Earnings Summary & Key Takeaways
- Press releaseGlobe Newswire
Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- NewsAvi Kapoor
Roku, SPS Commerce, Newell Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session
- NewsAvi Kapoor
Why Amazon Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- NewsNicolás Jose Rodriguez
Nasdaq-Traded Cannabinoid Biotech Corbus Pharma Stock Plunges 60%, But Analysts Say 'Buy The Dip' Now
- NewsAvi Kapoor
Crude Oil Moves Higher; Sable Offshore Shares Slide
- NewsAvi Kapoor
Gold Gains Over 1%; Battalion Oil Shares Spike Higher
- NewsRolando García
Corbus Pharma (CRBP) Stock Drops 60% After Novo Nordisk's Cannabinoid-Based Weight Loss Drug Trial Disappoints
- NewsNicolás Jose Rodriguez
Cannabis Stocks React To Trump's Marijuana Comments: See Which Ones Posted Solid Gains
- News
10 Health Care Stocks Whale Activity In Today's Session
- NewsMichael Juliano
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing (CORRECTED)
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.